BioScrip Investors Urge Del. Justices To Revive Lawsuit

Investors in home infusion company BioScrip Inc. told Delaware's Supreme Court justices Thursday that a faulty ruling on the timing of their complaint and company hostility to their claims against directors...

Already a subscriber? Click here to view full article